Cargando…

Scoring the Sit-to-Stand Performance of Parkinson’s Patients with a Single Wearable Sensor

Monitoring disease progression in Parkinson’s disease is challenging. Postural transfers by sit-to-stand motions are adapted to trace the motor performance of subjects. Wearable sensors such as inertial measurement units allow for monitoring motion performance. We propose quantifying the sit-to-stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, Frédéric, Warmerdam, Elke, Marin, Zoé, Ben Mansour, Khalil, Maetzler, Walter, Hansen, Clint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654014/
https://www.ncbi.nlm.nih.gov/pubmed/36366038
http://dx.doi.org/10.3390/s22218340
Descripción
Sumario:Monitoring disease progression in Parkinson’s disease is challenging. Postural transfers by sit-to-stand motions are adapted to trace the motor performance of subjects. Wearable sensors such as inertial measurement units allow for monitoring motion performance. We propose quantifying the sit-to-stand performance based on two scores compiling kinematics, dynamics, and energy-related variables. Three groups participated in this research: asymptomatic young participants (n = 33), senior asymptomatic participants (n = 17), and Parkinson’s patients (n = 20). An unsupervised classification was performed of the two scores to differentiate the three populations. We found a sensitivity of 0.4 and a specificity of 0.96 to distinguish Parkinson’s patients from asymptomatic subjects. In addition, seven Parkinson’s patients performed the sit-to-stand task “ON” and “OFF” medication, and we noted the scores improved with the patients’ medication states (MDS-UPDRS III scores). Our investigation revealed that Parkinson’s patients demonstrate a wide spectrum of mobility variations, and while one inertial measurement unit can quantify the sit-to-stand performance, differentiating between PD patients and healthy adults and distinguishing between “ON” and “OFF” periods in PD patients is still challenging.